title: Severe neuropathy in a patient with Waldenstrom disease: from a challenging diagnosis to clinical improvement by innovative therapy.
authors.forename: P
authors.initials: P
authors.lastname: Bertazzoni
authors.forename: G
authors.initials: G
authors.lastname: Andreola
authors.forename: D
authors.initials: D
authors.lastname: Laszlo
authors.forename: A
authors.initials: A
authors.lastname: Agazzi
authors.forename: S
authors.initials: S
authors.lastname: Bassi
authors.forename: F
authors.initials: F
authors.lastname: Gigli
authors.forename: G
authors.initials: G
authors.lastname: Martinelli
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D058846:Antibodies, Monoclonal, Murine-Derived; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D017338:Cladribine / Q000008:administration & dosage; D006801:Humans; D008297:Male; D008875:Middle Aged; D010523:Peripheral Nervous System Diseases / Q000175:diagnosis* / Q000188:drug therapy*; D000069283:Rituximab; D008258:Waldenstrom Macroglobulinemia / Q000150:complications* / Q000188:drug therapy
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D017338:Cladribine; D000069283:Rituximab